Wellington Management Group LLP 13D and 13G filings for Verve Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-06 2:58 pm Sale |
2022-12-30 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Management Group LLP | 859,102 1.390% |
-3,080,406 (-78.19%) |
Filing |
| 2022-02-04 09:24 am Purchase |
2021-12-31 | 13G | Verve Therapeutics, Inc. VERV |
Wellington Management Group LLP | 3,939,508 8.180% |
3,939,508 (New Position) |
Filing |